Status:
COMPLETED
Three Treatment of Chronic Obstructive Pulmonary Disease Patients
Lead Sponsor:
Tanta University
Conditions:
COPD
Eligibility:
All Genders
30-70 years
Phase:
PHASE4
Brief Summary
Forty five COPD patients will be recruited from Chest Disease Department, Tanta University Hospital, Tanta, Egypt. The aim of the study is to Compare between the effectiveness of three therapeutic op...
Detailed Description
This study will be prospective randomized double blind study. The forty five COPD patients will be divided into three groups: Group 1: 15 patients with COPD who will receive inhaled corticosteroid (...
Eligibility Criteria
Inclusion
- Age from 30 to 40 years or older.
- Patient with 30%≥ FEV1\<80% predicted and FEV1/FVC \<70% predicted.
Exclusion
- Patients with FEV1\< 30% predicted or FEV1\< 50% predicted plus chronic respiratory failure.
- Patients with recent chest infection or had been hospitalised for an exacerbation or respiratory infection in the 6 weeks before screening.
- Patients with history of asthma.
- Patient with clinically significant condition ex; unstable ischemic heart disease, uncontrolled hypertension, uncontrolled diabetes.
Key Trial Info
Start Date :
October 31 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04520230
Start Date
October 31 2014
End Date
December 31 2019
Last Update
August 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.